113 related articles for article (PubMed ID: 17079454)
1. Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis.
Hayama S; Daigo Y; Kato T; Ishikawa N; Yamabuki T; Miyamoto M; Ito T; Tsuchiya E; Kondo S; Nakamura Y
Cancer Res; 2006 Nov; 66(21):10339-48. PubMed ID: 17079454
[TBL] [Abstract][Full Text] [Related]
2. siRNA-mediated knockdown against CDCA1 and KNTC2, both frequently overexpressed in colorectal and gastric cancers, suppresses cell proliferation and induces apoptosis.
Kaneko N; Miura K; Gu Z; Karasawa H; Ohnuma S; Sasaki H; Tsukamoto N; Yokoyama S; Yamamura A; Nagase H; Shibata C; Sasaki I; Horii A
Biochem Biophys Res Commun; 2009 Dec; 390(4):1235-40. PubMed ID: 19878654
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis.
Hayama S; Daigo Y; Yamabuki T; Hirata D; Kato T; Miyamoto M; Ito T; Tsuchiya E; Kondo S; Nakamura Y
Cancer Res; 2007 May; 67(9):4113-22. PubMed ID: 17483322
[TBL] [Abstract][Full Text] [Related]
4. A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis.
Kato T; Daigo Y; Hayama S; Ishikawa N; Yamabuki T; Ito T; Miyamoto M; Kondo S; Nakamura Y
Cancer Res; 2005 Jul; 65(13):5638-46. PubMed ID: 15994936
[TBL] [Abstract][Full Text] [Related]
5. Identification of COX17 as a therapeutic target for non-small cell lung cancer.
Suzuki C; Daigo Y; Kikuchi T; Katagiri T; Nakamura Y
Cancer Res; 2003 Nov; 63(21):7038-41. PubMed ID: 14612491
[TBL] [Abstract][Full Text] [Related]
6. The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer.
Takahashi K; Furukawa C; Takano A; Ishikawa N; Kato T; Hayama S; Suzuki C; Yasui W; Inai K; Sone S; Ito T; Nishimura H; Tsuchiya E; Nakamura Y; Daigo Y
Cancer Res; 2006 Oct; 66(19):9408-19. PubMed ID: 17018595
[TBL] [Abstract][Full Text] [Related]
7. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression.
Hirata D; Yamabuki T; Miki D; Ito T; Tsuchiya E; Fujita M; Hosokawa M; Chayama K; Nakamura Y; Daigo Y
Clin Cancer Res; 2009 Jan; 15(1):256-66. PubMed ID: 19118053
[TBL] [Abstract][Full Text] [Related]
8. Activation of placenta-specific transcription factor distal-less homeobox 5 predicts clinical outcome in primary lung cancer patients.
Kato T; Sato N; Takano A; Miyamoto M; Nishimura H; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Clin Cancer Res; 2008 Apr; 14(8):2363-70. PubMed ID: 18413826
[TBL] [Abstract][Full Text] [Related]
9. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
Ishikawa N; Takano A; Yasui W; Inai K; Nishimura H; Ito H; Miyagi Y; Nakayama H; Fujita M; Hosokawa M; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Cancer Res; 2007 Dec; 67(24):11601-11. PubMed ID: 18089789
[TBL] [Abstract][Full Text] [Related]
10. Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells.
Li L; Yang L; Scudiero DA; Miller SA; Yu ZX; Stukenberg PT; Shoemaker RH; Kotin RM
Gene Ther; 2007 May; 14(10):814-27. PubMed ID: 17330085
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu.
Ren XL; Xu YM; Bao W; Fu HJ; Wu CG; Zhao Y; Li ZK; Zhang J; Li SQ; Chen WQ; Wang T; Zhang R; Zhang LH; Qian GS; Chen SY; Jia LT; Yang AG
Cancer Lett; 2009 Aug; 281(2):134-43. PubMed ID: 19339104
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target.
Fan T; Li R; Todd NW; Qiu Q; Fang HB; Wang H; Shen J; Zhao RY; Caraway NP; Katz RL; Stass SA; Jiang F
Cancer Res; 2007 Aug; 67(16):7901-6. PubMed ID: 17699796
[TBL] [Abstract][Full Text] [Related]
13. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
14. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
16. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas.
Yamabuki T; Takano A; Hayama S; Ishikawa N; Kato T; Miyamoto M; Ito T; Ito H; Miyagi Y; Nakayama H; Fujita M; Hosokawa M; Tsuchiya E; Kohno N; Kondo S; Nakamura Y; Daigo Y
Cancer Res; 2007 Mar; 67(6):2517-25. PubMed ID: 17363569
[TBL] [Abstract][Full Text] [Related]
17. Interference with netrin-1 and tumor cell death in non-small cell lung cancer.
Delloye-Bourgeois C; Brambilla E; Coissieux MM; Guenebeaud C; Pedeux R; Firlej V; Cabon F; Brambilla C; Mehlen P; Bernet A
J Natl Cancer Inst; 2009 Feb; 101(4):237-47. PubMed ID: 19211441
[TBL] [Abstract][Full Text] [Related]
18. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY
Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792
[TBL] [Abstract][Full Text] [Related]
19. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma.
Makita Y; Murata S; Katou Y; Kikuchi K; Uejima H; Teratani M; Hoashi Y; Kenjo E; Matsumoto S; Nogami M; Otake K; Kawamata Y
Biochem Biophys Res Commun; 2017 Nov; 493(1):800-806. PubMed ID: 28843857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
